Boehringer Ingelheim's Interactive Video Project Wins Award

Boehringer Ingelheim, which develops life-transforming treatments for today and future generations, has been recognized with a Gold Award at the Stevie Awards for its "Interactive Video Project".

The project, aimed at healthcare professionals working particularly in the field of pulmonary diseases to acquire knowledge and gain experience regarding Idiopathic Pulmonary Fibrosis (IPF), a rare disease, reached approximately 1,800 physicians. Within the scope of the project offering innovative solutions, specialists were enabled to quickly access the information they need during diagnosis and treatment processes and to take specific actions suited to the patient's condition.

Boehringer Ingelheim, which continues its operations with the mission of developing groundbreaking treatments that will improve and transform lives today and for generations to come, is recognized as one of the sector's largest investors in research and development and focuses on developing innovative treatments in areas where unmet medical needs are high. Undertaking an important mission for public health, Boehringer Ingelheim continues to provide solutions in the field of rare diseases and to assume a trusted guiding role in patients' disease journey.

The company, in this context, launched the Interactive Video Project, which will enable physicians to optimize the patient journey in combating Idiopathic Pulmonary Fibrosis (IPF), a rare disease, to quickly access the information they need during diagnosis and treatment processes, and to take specific actions suited to the patient's condition. The project was recognized with a Gold Award by the Stevie Awards, one of the most prestigious award programs in its field, organized to honor the achievements and positive contributions of organizations and business professionals worldwide.

Patient-Focused Project Developed Particularly for Pulmonology Specialists

During the project preparation process, the aim was to enable healthcare professionals working particularly in the field of pulmonary diseases to acquire knowledge and gain experience regarding Idiopathic Pulmonary Fibrosis (IPF). Within the scope of this project offering innovative solutions, approximately 1,800 physicians in Turkey were reached. Developed particularly for pulmonology specialists, the project enabled specialists to optimize the patient journey and to quickly access the information they need during diagnosis and treatment processes and to make specific treatment decisions suited to the patient's condition.